Smartleaf Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Smartleaf Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.6K	Buy	1,325 +614	+86%	+$35.8K	﹤0.01%	1267
2025 Q4	$41.9K	Sell	711 -38	-5%	-$2.07K	﹤0.01%	1639
2025 Q3	$40.5K	Buy	749 +360	+93%	+$20.6K	﹤0.01%	1491
2025 Q2	$21.5K	Sell	389 -312	-45%	-$18.4K	﹤0.01%	1518
2025 Q1	$50.1K	Sell	701 -184	-21%	-$12.4K	﹤0.01%	1145
2024 Q4	$57.9K	Buy	885 +466	+111%	+$31.2K	0.01%	1111
2024 Q3	$29.6K	Buy	419 +315	+303%	+$26.3K	﹤0.01%	1127
2024 Q2	$8.68K	Buy	104 +94	+940%	+$7.83K	﹤0.01%	1487
2024 Q1	$886	Buy	+10	New	+$895	﹤0.01%	1643

Other funds holding BMRN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return